TY - JOUR
T1 - Model Comparisons of the Effectiveness and Cost-Effectiveness of Vaccination
T2 - A Systematic Review of the Literature
AU - Drolet, Mélanie
AU - Bénard, Élodie
AU - Jit, Mark
AU - Hutubessy, Raymond
AU - Brisson, Marc
N1 - Publisher Copyright:
© 2018 ISPOR–The Professional Society for Health Economics and Outcomes Research.
PY - 2018/10
Y1 - 2018/10
N2 - Objectives: To describe all published articles that have conducted comparisons of model-based effectiveness and cost-effectiveness results in the field of vaccination. Specific objectives were to 1) describe the methodologies used and 2) identify the strengths and limitations of the studies. Methods: We systematically searched MEDLINE and Embase databases for studies that compared predictions of effectiveness and cost-effectiveness of vaccination of two or more mathematical models. We categorized studies into two groups on the basis of their data source for comparison (previously published results or new simulation results) and performed a qualitative synthesis of study conclusions. Results: We identified 115 eligible articles (only 5% generated new simulations from the reviewed models) examining the effectiveness and cost-effectiveness of vaccination against 14 pathogens (69% of studies examined human papillomavirus, influenza, and/or pneumococcal vaccines). The goal of most of studies was to summarize evidence for vaccination policy decisions, and cost-effectiveness was the most frequent outcome examined. Only 33%, 25%, and 3% of studies followed a systematic approach to identify eligible studies, assessed the quality of studies, and performed a quantitative synthesis of results, respectively. A greater proportion of model comparisons using published studies followed a systematic approach to identify eligible studies and to assess their quality, whereas more studies using new simulations performed quantitative synthesis of results and identified drivers of model conclusions. Most comparative modeling studies concluded that vaccination was cost-effective. Conclusions: Given the variability in methods used to conduct/report comparative modeling studies, guidelines are required to enhance their quality and transparency and to provide better tools for decision making.
AB - Objectives: To describe all published articles that have conducted comparisons of model-based effectiveness and cost-effectiveness results in the field of vaccination. Specific objectives were to 1) describe the methodologies used and 2) identify the strengths and limitations of the studies. Methods: We systematically searched MEDLINE and Embase databases for studies that compared predictions of effectiveness and cost-effectiveness of vaccination of two or more mathematical models. We categorized studies into two groups on the basis of their data source for comparison (previously published results or new simulation results) and performed a qualitative synthesis of study conclusions. Results: We identified 115 eligible articles (only 5% generated new simulations from the reviewed models) examining the effectiveness and cost-effectiveness of vaccination against 14 pathogens (69% of studies examined human papillomavirus, influenza, and/or pneumococcal vaccines). The goal of most of studies was to summarize evidence for vaccination policy decisions, and cost-effectiveness was the most frequent outcome examined. Only 33%, 25%, and 3% of studies followed a systematic approach to identify eligible studies, assessed the quality of studies, and performed a quantitative synthesis of results, respectively. A greater proportion of model comparisons using published studies followed a systematic approach to identify eligible studies and to assess their quality, whereas more studies using new simulations performed quantitative synthesis of results and identified drivers of model conclusions. Most comparative modeling studies concluded that vaccination was cost-effective. Conclusions: Given the variability in methods used to conduct/report comparative modeling studies, guidelines are required to enhance their quality and transparency and to provide better tools for decision making.
KW - comparative modeling studies
KW - effectiveness and cost-effectiveness
KW - infectious diseases
KW - systematic review of the literature
KW - vaccination
UR - http://www.scopus.com/inward/record.url?scp=85047254600&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85047254600&partnerID=8YFLogxK
U2 - 10.1016/j.jval.2018.03.014
DO - 10.1016/j.jval.2018.03.014
M3 - Review article
C2 - 30314627
AN - SCOPUS:85047254600
SN - 1098-3015
VL - 21
SP - 1250
EP - 1258
JO - Value in Health
JF - Value in Health
IS - 10
ER -